Trending News
News
News
COVID-19 Reinfection Likely Among Unvaccinated Individuals
Using a statistical model, researchers have assessed the durability of natural immunity against COVID-19, and have found that reinfection is likely among unvaccinated individuals.
News
Vaccines Over 90% Protective Effective at Preventing Death From Delta Variant
Research has found that the Pfizer-BioNTech vaccine is 90% effective and the Oxford-AstraZeneca vaccine 91% effective in preventing deaths from the Delta variant of COVID-19.
News
Moderna Boosters Are Equally Protective Against Variants
A booster dose of the mRNA-1273 COVID-19 vaccine given to rhesus macaques about six months after their primary vaccine series significantly increased levels of neutralizing antibodies against all known SARS-CoV-2 variants of concern, according to a new study from National Institutes of Health scientists and colleagues.
News
Antibody Can Detect and Destroy Senescent Cells
Researchers at the Universitat Oberta de Catalunya (UOC) and the University of Leicester have developed a new method to remove old cells from tissues, thus slowing down the ageing process.
News
Valneva Trial Compares New COVID-19 Vaccine to Oxford–AstraZeneca Vaccine
Speciality vaccine company Valneva has announced topline results from its Phase III trial of the inactivated, adjuvanted COVID-19 vaccine candidate VLA2001.
News
Immunity to Infection Passed On to Subsequent Generations
Does an infection also affect the immunization of subsequent generations? Mouse fathers who had previously overcome an infection with fungi or were stimulated with fungal compounds also passed on their improved protection to their offspring across several generations.
News
Building Stronger Anti-Cancer Therapies With Stem Cells
A new study shows how iPS cell technology can produce some of the most potent anti-cancer immune cells for adoptive cell therapies.
News
A Regenerative Reset for Aging
Regenerative medicine could slow the clock on degenerative diseases that often ravage the golden years, a Mayo Clinic study finds.
News
Children Born With Deadly Immune Condition Still Healthy 10 Years After Gene Therapy
The effects of a therapy developed to treat children born with a rare and deadly immune system disorder appear to be long-lasting as 90% of patients who received the treatment eight to 11 years ago are still disease-free.
News
New Genes Related to Fibromuscular Dysplasia Identified
According to a study, three new genetic variants that regulate gene expression in the arteries are connected to fibromuscular dysplasia.
Advertisement